Bococizumab is a novel anti-PCSK9 antibody specifically developed to address hypercholesterolemia. It therapeutic agent works by the PCSK9 protein, a critical regulator of cholesterol amounts. By neutralizing the https://miriamomdz904214.blog5.net/91675358/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia